IN8BIO INC INAB
ASignal's systematic analysis rates INAB as Bearish.
Reflects the latest available analysis · analyzed Nov 17, 2026
The case on INAB
Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.
- Strong financial health score (0.9)
- Low debt-to-equity ratio (0.19x)
- High current and quick ratios indicating strong liquidity
- Cash-rich balance sheet with $13.97M cash vs $2.75M debt
- Negative RSI (37.63) indicating weak momentum
- MACD below signal line with negative histogram
- Negative price momentum (-0.141)
- Negative return on equity (-141.83%) and return on assets (-70.34%)
- Negative free cash flow (-$7.93M)
- No Reddit mentions, suggesting lack of retail interest
See the full verdict on INAB
ASignal Rank (1-4), confidence score, Value / Activist / Macro grades, price targets, and the full reasoning behind the call.
How ASignal analyzes INAB
Most investors never get a second opinion, let alone several. ASignal runs INAB past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: value discipline, activist catalysts, and macro analysis. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.
The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.